openPR Logo
Press release

Gabapentin Market CAGR to be at 4.37% | $3,036.38 Million Industry Revenue By 2032

07-05-2024 07:37 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Gabapentin Market

Gabapentin Market

๐†๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง-๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ, ๐’๐ข๐ณ๐ž ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž, ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค, ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ, ๐š๐ง๐ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ. ๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐ ๐š๐›๐š๐ฉ๐ž๐ง๐ญ๐ข๐ง ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐š๐ฌ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž๐ ๐ญ๐จ ๐›๐ž ๐ฐ๐จ๐ซ๐ญ๐ก ๐”๐’๐ƒ ๐Ÿ,๐Ÿ—๐Ÿ–๐Ÿ.๐Ÿ”๐ŸŽ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ ๐š๐ง๐ ๐ข๐ฌ ๐ฉ๐ซ๐ž๐๐ข๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ž๐ฑ๐ฉ๐š๐ง๐ ๐ญ๐จ ๐”๐’๐ƒ ๐Ÿ‘,๐ŸŽ๐Ÿ‘๐Ÿ”.๐Ÿ‘๐Ÿ– ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ฐ๐ข๐ญ๐ก ๐š ๐‚๐€๐†๐‘ ๐จ๐Ÿ ๐Ÿ’.๐Ÿ‘๐Ÿ•% ๐๐ฎ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ž๐œ๐š๐ฌ๐ญ ๐ฉ๐ž๐ซ๐ข๐จ๐ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘-๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ.

๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐œ๐จ๐ฉ๐ž:

This comprehensive study provides an accurate overview of the worldwide gabapentin industry. It includes comprehensive analyses of sales volume, price, revenue, market share, and important companies. The market is further divided into segments by dosage, type, application, distribution channel, and region, offering a comprehensive picture of the gabapentin market state.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐ญ๐จ ๐†๐š๐ข๐ง ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ : https://www.polarismarketresearch.com/industry-analysis/gabapentin-market/request-for-sample

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ž๐Ÿ๐ข๐ง๐ข๐ญ๐ข๐จ๐ง:

Among other names, gabapentin is a brand-named anticonvulsant drug that is mostly prescribed to treat neuropathic pain and partial seizures. It is a drug that is frequently used to treat central pain, postherpetic neuralgia, and neuropathic pain brought on by diabetic neuropathy. The most frequent adverse effects are tiredness and lightheadedness. An increased risk of suicide, respiratory depression, and allergic reactions are examples of serious adverse effects. For people with renal illness, lower doses are advised. A subgroup of calcium channels had their activity reduced by gabapentin.

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐“๐ซ๐ž๐ง๐๐ฌ:

โ— As the population ages, chronic pain and neurological illnesses are predicted to become more common, increasing demand for drugs such as gabapentin.

โ— The rise of e-commerce has made it easier for people to buy pharmaceuticals like gabapentin online, boosting access to the drug for patients who may not have easy access to a traditional pharmacy.

๐“๐จ๐ฉ ๐‚๐จ๐ฆ๐ฉ๐š๐ง๐ข๐ž๐ฌ:

Because there are so many companies in the industry, it is expected to be both competitive and fragmented. Here are the top companies in the gabapentin market:
โ€ข Pfizer Inc.
โ€ข Teva Pharmaceutical Industries Ltd.
โ€ข Sun Pharmaceutical Industries Ltd. Aurobindo Pharma Ltd.
โ€ข Lupin Limited
โ€ข Mylan N.V.
โ€ข Cipla Limited
โ€ข Hikma Pharmaceuticals PLC
โ€ข Arbor Pharmaceuticals Inc.
โ€ข Zydus Cadila Healthcare Limited
โ€ข Glenmark Pharmaceuticals Ltd.
โ€ข Apotex Inc.
โ€ข Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd.
โ€ข Wockhardt Ltd

๐‚๐ฅ๐ข๐œ๐ค ๐จ๐ง ๐ญ๐ก๐ž ๐๐ž๐ฅ๐จ๐ฐ ๐‹๐ข๐ง๐ค ๐ญ๐จ ๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ : https://www.polarismarketresearch.com/buy/2178/2

๐‚๐จ๐ฎ๐ง๐ญ๐ซ๐ฒ-๐–๐ข๐ฌ๐ž ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ:

According to regional research, the demand in North America is expected to witness significant growth during the forecast period. The demand for Gabapentin is expected to increase in various regions due to its efficacy and safety profile. Also, the Asia-Pacific region is expected to witness significant growth in the demand for gabapentin due to the increasing prevalence of neurological disorders, such as epilepsy and neuropathic pain. The rising healthcare spending and increasing awareness about the benefits of gabapentin are expected to drive the demand for the medication in the region.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค:

๐˜ฝ๐™ฎ ๐˜ฟ๐™ค๐™จ๐™–๐™œ๐™š :

โ€ข Capsule
โ€ข Tablet

๐˜ฝ๐™ฎ ๐™๐™ฎ๐™ฅ๐™š :

โ€ข Branded
โ€ข Generic

๐˜ฝ๐™ฎ ๐˜ผ๐™ฅ๐™ฅ๐™ก๐™ž๐™˜๐™–๐™ฉ๐™ž๐™ค๐™ฃ :

โ€ข Neuropathic Pain
โ€ข Epilepsy
โ€ข Restless Legs Syndrome
โ€ข Others

๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐“๐Ž๐‚ ๐ฐ๐ข๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐ž๐ฏ๐ข๐ž๐ฐ: https://www.polarismarketresearch.com/industry-analysis/gabapentin-market

๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐“๐Ž๐‚ ๐ฐ๐ข๐ญ๐ก ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐ž๐ฏ๐ข๐ž๐ฐ:

๐™Š๐™ฅ๐™๐™ฉ๐™๐™–๐™ก๐™ข๐™ž๐™˜ ๐˜ฟ๐™ง๐™ช๐™œ๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/ophthalmic-drug-market
๐™ˆ๐™ฎ๐™–๐™จ๐™ฉ๐™๐™š๐™ฃ๐™ž๐™– ๐™‚๐™ง๐™–๐™ซ๐™ž๐™จ ๐˜ฟ๐™ž๐™จ๐™š๐™–๐™จ๐™š ๐™๐™ง๐™š๐™–๐™ฉ๐™ข๐™š๐™ฃ๐™ฉ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/myasthenia-gravis-disease-treatment-market
๐™‰๐™š๐™ช๐™ง๐™ค๐™ก๐™ค๐™œ๐™ž๐™˜๐™–๐™ก ๐˜ฝ๐™ž๐™ค๐™ข๐™–๐™ง๐™ ๐™š๐™ง๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/neurological-biomarkers-market
๐™„๐™ค๐™ ๐™ˆ๐™š๐™™๐™ž๐™˜๐™–๐™ก ๐˜ฟ๐™š๐™ซ๐™ž๐™˜๐™š๐™จ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/iot-medical-devices-market
๐˜พ๐™š๐™ก๐™ก ๐˜ฟ๐™ž๐™จ๐™จ๐™ค๐™˜๐™ž๐™–๐™ฉ๐™ž๐™ค๐™ฃ ๐™ˆ๐™–๐™ง๐™ ๐™š๐™ฉ : https://www.polarismarketresearch.com/industry-analysis/cell-dissociation-market

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:
Polaris Market Research
Phone: +1-929-297-9727
Email: sales@polarismarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defence, among different ventures present globally.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gabapentin Market CAGR to be at 4.37% | $3,036.38 Million Industry Revenue By 2032 here

News-ID: 3567124 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of 5.2%
Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of โ€ฆ
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors. Market at a Glance In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. Itโ€ฆ
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 Billion by 2034, Growing at a CAGR of 7.5%
Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 โ€ฆ
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 3.82 billion in 2024 and is expected toโ€ฆ
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expanding at a CAGR of 6.8%
Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin โ€ฆ
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billionโ€ฆ
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2034, Growing at a CAGR of 7.44%
Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 โ€ฆ
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape. According to the findings, the market stood at 31.67 billion in 2024 and is expected to reachโ€ฆ

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 โ€ฆ
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about theโ€ฆ